Legend Biotech Corp ADR (LEGN): A Great Stock For Handling Current Market Conditions?
Currently, there are 183.65M common shares owned by the public and among those 181.14M shares have been available to trade. The company’s stock has a 5-day price change of 9.65% and 6.64% over the past three months. LEGN shares are trading 3.69% year to date (YTD), with the 12-month market performance down to -36.24% lower. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Legend Biotech Corp ADR (NASDAQ: LEGN)
T. Rowe Price Associates, Inc. recently announced the acquisition of new stake in Legend Biotech Corp ADR (NASDAQ:LEGN). The institutional investor has increased its shareholding in the Healthcare company by 7.33% to 9.69 million shares with purchase of 0.66 million shares. This fresh investment now brings its stake to 5.33% valued currently at $589.43 million. […]
